Health Care/Hospital

DarwinHealth Announces Compound-2-Clinic (C2C) Scientific Collaboration with Celgene to Deploy a Quantitative Systems Biology Discovery Platform to Characterize Celgene Oncology Compounds

NEW YORK, Aug. 30, 2019 /PRNewswire/ -- DarwinHealth today announced a multi-year scientific research collaboration with Celgene Corporation ("Celgene") to use quantitative systems biology-based algorithms, technologies that also underpin NY State CLIA-approved diagnostic tests in oncology, and ...

2019-08-30 01:59 1822

SC Johnson Spatial Repellent Innovation Provides New Potential Solution for Communities in Malaria-Endemic Areas

New Study Demonstrates Positive Results in Reducing Transmission of Malaria in Indonesia RACINE, Wisconsin, Aug. 30, 2019 /PRNewswire/ -- The World Health Organization (WHO) recently posted a report showing the effectiveness of spatial repellents in fighting malaria. The data outcomes came from...

2019-08-30 00:08 1698

Ajinomoto Bio-Pharma Services Acquires Remaining Interest in Granules OmniChem Joint Venture in India

WETTEREN, Belgium, Aug. 29, 2019 /PRNewswire/ -- Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, announced today its intention to purchase the remaining 50 percent ownership interest in its Visakhapatnam,In...

2019-08-29 20:04 1699

With AI Empowering Healthcare, Ping An Good Doctor Showed Nine Black Technology Products at The World Artificial Intelligence Conference 2019

SHANGHAI, Aug. 29, 2019 /PRNewswire/ -- On 29 August 2019, the World Artificial Intelligence Conference opened in Shanghai World Expo Center and Expo Exhibition Hall. The world's leading healthcare ecosystem platform,Ping An Healthcare and Technology Company Limited("Ping An Good Doctor", stock c...

2019-08-29 17:14 6847

Luye Pharma First Half of 2019 Results: Strong Revenue Growth and Substantial Development of R&D Product Pipelines

SHANGHAI, Aug. 29, 2019 /PRNewswire/ -- Luye Pharma Group (02186.HK) released its financial results for the first half of 2019 onAugust 28. The results show the company has achieved a revenue ofRMB 3.131 billion, up 42.1% year-on-year; EBITDA reachedRMB 1.263 billion, up 44.1% year-on-year, while...

2019-08-29 16:34 11032

Taiho Pharmaceutical Invests in New Venture Capital Fund

TOKYO, Aug. 29, 2019 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd. (HQ: Tokyo, President and Representative Director:Masayuki Kobayashi) announced on August 29 that the company has entered into an agreement to invest up toUS$30 million in Remiges Biopharma Fund II, LP a biopharma venture capital...

2019-08-29 13:00 1340

Viva Biotech Announces 2019 Interim Results

Financial Highlights * Revenue grew significantly by 83.9% YoY from RMB77.4 million to approximatelyRMB142.3 million. * Gross profit recorded approximately RMB71.9 million, growing significantly by 70.0% fromRMB42.3 million. * Net profit excluding extraordinary profit or loss increased sig...

2019-08-29 11:12 4226

Esco Ventures Announces the Launch of Carmine Therapeutics, a Company Pioneering Red Blood Cell (RBC)-Derived Extracellular Vesicle (EV)-Based Gene Therapies

SINGAPORE, Aug. 29, 2019 /PRNewswire/ -- Esco Ventures is pleased to announce the launch of Carmine Therapeutics and execution of an exclusive license agreement for the technology developed in the laboratories of ProfessorsMinh Le and Jiahai Shi at the CityUniversity of Hong Kong. Carmine Therape...

2019-08-29 11:00 1566

Innovent Reports Interim Results for Fiscal Year 2019

SUZHOU, China, Aug. 29, 2019 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines, today announced its interim financial results for the six months endedJune 30, 2019. HIGHLIGHTS AND OTH...

2019-08-29 08:39 1696

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Announces Management of Most Adult Cancers Covered by NCCN Harmonized Guidelines

National Comprehensive Cancer Network, African Cancer Coalition, and American Cancer Society launch new phase focused on updating adult cancer guidelines and adding new guidelines for treating children with cancer. NCCN Harmonized Guidelines™ for Sub-Saharan Africa endorsed in six countries repr...

2019-08-28 19:12 1610

International Collaboration to Improve Cancer Care in Sub-Saharan Africa Announces Management of Most Adult Cancers Covered by NCCN Harmonized Guidelines

National Comprehensive Cancer Network, African Cancer Coalition, and American Cancer Society launch new phase focused on updating adult cancer guidelines and adding new guidelines for treating children with cancer. NCCN Harmonized Guidelines™ for Sub-Saharan Africa endorsed in six countries repr...

2019-08-28 19:00 1577

Medtec China 2019 to inaugurate on September 25 in Shanghai

SHANGHAI, Aug. 28, 2019 /PRNewswire/ -- Medtec China 2019 will be inaugurated on September 25 in Shanghai. Compared to last year, the scale of Medtec China 2019 will expand by 30%, hitting a new high in its history. Medtec China will gather 450+ exhibitors of quality brands from medical design and...

2019-08-28 11:12 1511

Ascletis Received IND Approval for its NASH Drug

HANGZHOU, China and SHAOXING, China, Aug. 28, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that toget...

2019-08-28 08:00 1506

LBB Specialties Announces Strategic Partnership With MEGGLE On US Distribution Of Excipient Products

NORWALK, Connecticut, Aug. 28, 2019 /PRNewswire/ -- LBB Specialties announced that effectiveAugust 1, 2019, LBB has entered into a strategic partnership with MEGGLE Excipients & Technology to distribute MEGGLE's excipient products to companies in the American pharmaceutical and nutraceutical indu...

2019-08-28 06:00 1004

Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020

1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million )                                   Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($16.4 Million) Non-GAAP Operating Income Up 15.0% YoY to RMB...

2019-08-28 04:16 7678

Global Cord Blood Corporation Reports Financial Results for the First Quarter of Fiscal 2020

1Q20 Added 20,815 New Subscribers Revenues Up 16.9% YoY to RMB273.4 Million ($39.8 Million )                                   Gross Profit Up 19.4% YoY to RMB227.6 million ($33.2 million) Operating Income Up 17.8% YoY to RMB112.4 Million ($16.4 Million) Non-GAAP Operating Income Up 15.0% YoY to RMB...

2019-08-28 04:16 7964

CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Texas

The procedure was performed by Joseph M. Berman, MD, an orthopedic surgeon at Arlington Orthopedics Associates (AOA),Arlington, TX KFAR SABA, Israel, Aug. 27, 2019 /PRNewswire/ — CartiHeal , developer of Agili-C™, a proprietary implant for the treatment of cartilage le...

2019-08-27 22:24 1277

Nut Molecules May Help Improve Inflammatory and Metabolic Profile of Fat Cells

REUS, Spain, Aug. 27, 2019 /PRNewswire/ -- A recent INC-funded study, published in the journalCommunications Biology1, showed that some nuts such as walnuts and hazelnuts may help improve the metabolic profile of fat cells. The study also revealed novel anti-inflammatory functions of these nuts. ...

2019-08-27 22:10 1287

Origin Agritech Entered Collaboration Agreement with Biotechnology Research Institute of Chinese Academy of Agriculture Sciences to Speed up Commercialization of GM Traits in China

BEIJING, Aug. 27, 2019 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology and rural e-commerce company, today announced that the Company has entered into a collaboration agreement with Biotechnology Research Institute (BRI) of Chinese Academ...

2019-08-27 20:00 3618

Health Canada Clears Fotona Dynamis for Stress Urinary Incontinence (SUI) and Vulvovaginal Atrophy (VVA) / Genitourinary Syndrome of Menopause (GSM)

LJUBLJANA, Slovenia, Aug. 27, 2019 /PRNewswire/ -- In an industry first achievement, Fotona's Dynamis Laser System received clearance by Health Canada, Canada's Food and Drugs Act and Regulations Agency, to treat stress urinary incontinence (SUI) and vulvovaginal atrophy (VVA) / genitourinary synd...

2019-08-27 17:05 371
1 ... 567891011 ... 740